Foresite Capital Management III as of Dec. 31, 2019
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 10 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerie Pharmaceuticals | 31.8 | $57M | 2.4M | 24.17 | |
| Immunomedics | 20.8 | $37M | 1.8M | 21.16 | |
| Myokardia | 13.3 | $24M | 327k | 72.89 | |
| Epizyme | 9.5 | $17M | 687k | 24.60 | |
| Audentes Therapeutics | 7.8 | $14M | 233k | 59.84 | |
| Acceleron Pharma | 7.6 | $14M | 255k | 53.02 | |
| Natera (NTRA) | 3.9 | $7.0M | 209k | 33.69 | |
| Replimune Group (REPL) | 2.5 | $4.5M | 314k | 14.35 | |
| Cymabay Therapeutics | 1.6 | $2.9M | 1.5M | 1.96 | |
| Ascendis Pharma A S (ASND) | 1.1 | $1.9M | 14k | 139.13 |
